Predilife SA
ALPRE
Company Profile
Business description
Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
Contact
114 rue Edouard Vaillant Espace Maurice Tubiana
Villejuif
Paris94800
FRAT: +33 142114211
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
20
Stocks News & Analysis
stocks
Most popular shares in SMSFs
With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks
Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27
Charts from the Australian Dividend Outlook show the sectors where they are abundant.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,255.90 | 0.10 | 0.00% |
| CAC 40 | 8,041.36 | 18.77 | -0.23% |
| DAX 40 | 24,611.25 | 14.12 | 0.06% |
| Dow JONES (US) | 46,358.42 | 243.36 | -0.52% |
| FTSE 100 | 9,509.40 | 39.47 | -0.41% |
| HKSE | 26,752.59 | 76.87 | -0.29% |
| NASDAQ | 23,024.63 | 18.75 | -0.08% |
| Nikkei 225 | 48,396.96 | 183.48 | -0.38% |
| NZX 50 Index | 13,496.73 | 74.13 | -0.55% |
| S&P 500 | 6,735.11 | 18.61 | -0.28% |
| S&P/ASX 200 | 8,950.40 | 1.30 | 0.01% |
| SSE Composite Index | 3,933.97 | 51.20 | 1.32% |